Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.869 |
High Similarity |
NPD1247 |
Approved |
0.8675 |
High Similarity |
NPD3882 |
Suspended |
0.8443 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8266 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8225 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8198 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8166 |
Intermediate Similarity |
NPD1934 |
Approved |
0.814 |
Intermediate Similarity |
NPD919 |
Approved |
0.8068 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8023 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8011 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8011 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7977 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7964 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7901 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7802 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7759 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7747 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7747 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7735 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7692 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD6799 |
Approved |
0.768 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7661 |
Intermediate Similarity |
NPD920 |
Approved |
0.7651 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7647 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7647 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7637 |
Intermediate Similarity |
NPD7472 |
Approved |
0.763 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7596 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7557 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7545 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7472 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7471 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7442 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD6651 |
Approved |
0.741 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7396 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD943 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7381 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7337 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7246 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7238 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7174 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7151 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD447 |
Suspended |
0.712 |
Intermediate Similarity |
NPD5710 |
Approved |
0.712 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD3750 |
Approved |
0.711 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.71 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7056 |
Intermediate Similarity |
NPD37 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7035 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7033 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7033 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7033 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7027 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7015 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7015 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7015 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7011 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.701 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.6989 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6988 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.698 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6978 |
Remote Similarity |
NPD2296 |
Approved |
0.6977 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD6100 |
Approved |
0.6977 |
Remote Similarity |
NPD6099 |
Approved |
0.6976 |
Remote Similarity |
NPD7874 |
Approved |
0.6976 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6971 |
Remote Similarity |
NPD6190 |
Approved |
0.697 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6952 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6952 |
Remote Similarity |
NPD4665 |
Approved |
0.6946 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6936 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD8312 |
Approved |
0.6927 |
Remote Similarity |
NPD8313 |
Approved |
0.6914 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6893 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD9494 |
Approved |
0.6882 |
Remote Similarity |
NPD1613 |
Approved |
0.6882 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6864 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7801 |
Approved |
0.6854 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.685 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.685 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD6808 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6833 |
Remote Similarity |
NPD1653 |
Approved |
0.6823 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6821 |
Remote Similarity |
NPD3748 |
Approved |
0.6806 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6784 |
Remote Similarity |
NPD6535 |
Approved |
0.6784 |
Remote Similarity |
NPD6534 |
Approved |
0.6779 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6779 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD6279 |
Approved |
0.6776 |
Remote Similarity |
NPD6280 |
Approved |
0.6765 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6744 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6739 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6739 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.672 |
Remote Similarity |
NPD5242 |
Approved |
0.6716 |
Remote Similarity |
NPD3057 |
Approved |
0.6703 |
Remote Similarity |
NPD5353 |
Approved |
0.6698 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6686 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6684 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2654 |
Approved |
0.6667 |
Remote Similarity |
NPD2493 |
Approved |
0.6667 |
Remote Similarity |
NPD2494 |
Approved |
0.6667 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4287 |
Approved |
0.6651 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.665 |
Remote Similarity |
NPD8319 |
Approved |
0.665 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6649 |
Remote Similarity |
NPD7240 |
Approved |
0.6649 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD1933 |
Approved |
0.6636 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6634 |
Remote Similarity |
NPD2491 |
Approved |
0.6634 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6634 |
Remote Similarity |
NPD3533 |
Approved |
0.6634 |
Remote Similarity |
NPD2972 |
Approved |
0.6633 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6614 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6612 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6608 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6607 |
Remote Similarity |
NPD6696 |
Suspended |
0.6585 |
Remote Similarity |
NPD3450 |
Approved |
0.6585 |
Remote Similarity |
NPD3452 |
Approved |
0.6584
|
Remote Similarity |
NPD4361 |
Phase 2 |